(Q31030338)

English

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

Europe PubMed Central

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

King JE

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Thatcher N

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Pickering CA

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Hasleton PS

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

223-232

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Specific carcinoembryonic antigens of the human digestive system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

The use of vimentin antibodies in the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 14 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Hyaluronate binding probe and CD44 in the differential diagnosis of malignant effusions: disappointing results in cytology material

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Continuing increase in mesothelioma mortality in Britain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Are pathologists biased by clinical information?: A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

The Immunohistochemical Diagnostic Panel for Epithelial Mesothelioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02331.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2005.02331.X

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31030338&oldid=2165739637"